English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

A recent report in a peer-reviewed UK journal outlines five cases of optic neuropathy thought to be related to long-term treatment with selective serotonin reuptake inhibitors (SSRIs).1 These five were identified over a 2-year period within an island population of 140 000. Each case was assessed using the Naranjo algorithm to indicate likelihood of adverse drug reaction (ADR).2 The Naranjo scores indicated possible ADR in four cases and probable ADR in one case.All five cases presented with visual loss from suspected ischaemic optic neuropathy (ION) and were all extensively investigated for any other possible underlying cause. A ‘non-arteritic’ ischaemic origin was suspected in all cases. Toxicity was felt to be unlikely since three cases were of sudden onset and two cases were unilateral.Two cases …

Keep an eye on the SSRI: help avoid possible sight-threatening adverse events